FindTrial
Sign In

Immature platelet fraction in patients infected with COVID-19

Immature platelet fraction in patients diagnosed with COVID-19 - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060412
Enrollment
68
Registered
2023-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U071- COVID 19 virus identified

Interventions

Intervention1: Not applicable: Not applicable Control Intervention1: Not applicable: Not applicable

Sponsors

Rashmi Jain Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted to Lok Nayak Hospital who were diagnosed with COVID during the period of study from 4 January to 4 February 2022.

Exclusion criteria

Exclusion criteria: Patients whose platelet parameter immature platelet fraction was not done.

Design outcomes

Primary

MeasureTime frame
To analyse the immature platelet fraction in patients infected with COVID-19 with low platelet count and in patients infected with COVID-19 with normal platelet count.Timepoint: At baseline—

Secondary

MeasureTime frame
To analyse the mean platelet volume, platelet distribution width, plateletcrit and platelet large cell ratio in patients infected with COVID-19 with low platelet count and in patients infected with COVID-19 with normal platelet count.Timepoint: At baseline—

Countries

India

Contacts

Public ContactRashmi Jain Gupta

Lok Nayak Hospital

drrashmijaingupta@gmail.com9873617571

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026